Taoliang Chen

786 total citations
16 papers, 528 citations indexed

About

Taoliang Chen is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Taoliang Chen has authored 16 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Taoliang Chen's work include Nanoplatforms for cancer theranostics (4 papers), MicroRNA in disease regulation (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Taoliang Chen is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), MicroRNA in disease regulation (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). Taoliang Chen collaborates with scholars based in China, Taiwan and United States. Taoliang Chen's co-authors include Yiquan Ke, Jihui Wang, Xinlin Sun, Yan Li, Yuxuan Zhang, Min Huang, Yubo Zhu, Yun Wang, Jiansheng Chen and Xiao Li and has published in prestigious journals such as Oncogene, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Taoliang Chen

15 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Taoliang Chen China	12	379	275	89	64	61	16	528
Chia‐Ing Jan Taiwan	14	305 0.8×	151 0.5×	116 1.3×	142 2.2×	46 0.8×	21	633
Youxin Zhou China	12	633 1.7×	599 2.2×	44 0.5×	32 0.5×	48 0.8×	20	813
Nicole M. Kane United Kingdom	10	378 1.0×	155 0.6×	39 0.4×	13 0.2×	53 0.9×	15	475
Guishan Jin China	12	237 0.6×	120 0.4×	57 0.6×	140 2.2×	75 1.2×	31	464
Hilda Tsai United States	8	312 0.8×	147 0.5×	49 0.6×	168 2.6×	32 0.5×	11	457
Xiushan Feng China	7	196 0.5×	75 0.3×	70 0.8×	30 0.5×	99 1.6×	10	416
Raphaêl Lis United States	9	213 0.6×	168 0.6×	65 0.7×	207 3.2×	101 1.7×	10	448
Saeideh Ebrahimkhani Australia	8	530 1.4×	406 1.5×	54 0.6×	25 0.4×	75 1.2×	10	655
Yue Zhong China	12	492 1.3×	372 1.4×	52 0.6×	60 0.9×	74 1.2×	16	635
Oleta A. Sandiford United States	11	470 1.2×	357 1.3×	134 1.5×	217 3.4×	100 1.6×	18	722

Countries citing papers authored by Taoliang Chen

Since Specialization

Citations

This map shows the geographic impact of Taoliang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taoliang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taoliang Chen more than expected).

Fields of papers citing papers by Taoliang Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taoliang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taoliang Chen. The network helps show where Taoliang Chen may publish in the future.

Co-authorship network of co-authors of Taoliang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Taoliang Chen. A scholar is included among the top collaborators of Taoliang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taoliang Chen. Taoliang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Cai, Hongyi, Yang Liu, Chengcheng Ma, et al.. (2025). The timing of cranioplasty and the risk of postoperative complications: a systematic review and meta-analysis. EClinicalMedicine. 88. 103492–103492.

Ma, Chengcheng, Jiawen Chen, Yang Liu, et al.. (2024). Therapeutic modulation of APP-CD74 axis can activate phagocytosis of TAMs in GBM. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167449–167449. 12 indexed citations

Chen, Huajian, Li Zhang, Taoliang Chen, et al.. (2024). Nanoparticles Coated with Brain Microvascular Endothelial Cell Membranes can Target and Cross the Blood–Brain Barrier to Deliver Drugs to Brain Tumors. Small. 20(29). e2306714–e2306714. 20 indexed citations

Ma, Chengcheng, et al.. (2023). Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy. Journal of Neuro-Oncology. 165(1). 79–90. 4 indexed citations

Chen, Huajian, et al.. (2023). Inflammatory responsive neutrophil-like membrane-based drug delivery system for post-surgical glioblastoma therapy. Journal of Controlled Release. 362. 479–488. 19 indexed citations

Liu, Jie, et al.. (2022). A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma. Frontiers in Genetics. 13. 1026192–1026192. 1 indexed citations

Chen, Taoliang, et al.. (2021). Dual role of WNT5A in promoting endothelial differentiation of glioma stem cells and angiogenesis of glioma derived endothelial cells. Oncogene. 40(32). 5081–5094. 16 indexed citations

Xu, Xiangdong, Yang Liu, Yan Li, et al.. (2021). Selective exosome exclusion of miR-375 by glioma cells promotes glioma progression by activating the CTGF-EGFR pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 16–16. 31 indexed citations

Liu, Limin, et al.. (2020). si-SNHG5-FOXF2 inhibits TGF-β1-induced fibrosis in human primary endometrial stromal cells by the Wnt/β-catenin signalling pathway. Stem Cell Research & Therapy. 11(1). 479–479. 43 indexed citations

10.

Chen, Huajian, Qizhi Luo, Jihui Wang, et al.. (2020). Response of pH-Sensitive Doxorubicin Nanoparticles on Complex Tumor Microenvironments by Tailoring Multiple Physicochemical Properties. ACS Applied Materials & Interfaces. 12(20). 22673–22686. 22 indexed citations

11.

Liu, Jie, Yuxuan Zhang, Taoliang Chen, et al.. (2020). Environmentally Self-Adaptative Nanocarriers Suppress Glioma Proliferation and Stemness via Codelivery of shCD163 and Doxorubicin. ACS Applied Materials & Interfaces. 12(47). 52354–52369. 15 indexed citations

12.

Chen, Jiansheng, Taoliang Chen, Yubo Zhu, et al.. (2019). circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma. Journal of Experimental & Clinical Cancer Research. 38(1). 398–398. 195 indexed citations

13.

Li, F., Yuqin Yang, Xiangdong Xu, et al.. (2018). IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma. Oncogene. 38(11). 1815–1831. 86 indexed citations

14.

Chen, Taoliang, Jiansheng Chen, Yubo Zhu, et al.. (2018). CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2. Oncogene. 38(8). 1183–1199. 43 indexed citations

15.

Sun, Xinlin, Jihui Wang, Min Huang, et al.. (2018). STAT3 promotes tumour progression in glioma by inducing FOXP1 transcription. Journal of Cellular and Molecular Medicine. 22(11). 5629–5638. 20 indexed citations

16.

Qiu, Qianqian, Qiongyao Wang, Yanqin Sun, et al.. (2016). Small molecular peptide-ScFv αvβ3 conjugates specifically inhibit lung cancer cell growth in vitro and in vivo.. PubMed. 6(12). 2846–2858. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact